Psychiatry diagnoses and treats mental health conditions, including depression, anxiety, bipolar disorder, and schizophrenia.
Send us all your questions or requests, and our expert team will assist you.
Effective diagnosis and evaluation form the cornerstone of successful treatment for alcohol use disorder (AUD). This page provides a detailed roadmap for clinicians and international patients seeking a clear understanding of how AUD is identified, measured, and prepared for personalized care at Liv Hospital. Did you know that worldwide, over 283 million people experience alcohol‑related health issues each year? Recognizing the disorder early through systematic assessment dramatically improves outcomes.
We will walk you through the entire assessment pathway—from the initial clinical interview to laboratory investigations, diagnostic criteria, and specialized assessment tools. Whether you are a patient planning to travel for care or a healthcare professional coordinating cross‑border treatment, the information below equips you with the knowledge needed to navigate the process confidently.
Alcohol use disorder is a chronic medical condition characterized by an impaired ability to stop or control alcohol use despite adverse consequences. It affects individuals across cultures, ages, and socioeconomic backgrounds, making a universal approach to diagnosis and evaluation essential.
Key aspects of AUD include:
From a public‑health perspective, AUD contributes to over 3 million deaths annually, representing 5 % of the global disease burden. Early detection through structured assessment reduces the risk of liver cirrhosis, cardiovascular disease, and mental health comorbidities.
At Liv Hospital, the evaluation process is tailored for international patients, integrating cultural sensitivity with evidence‑based practices to ensure accurate identification of the disorder.
The first step in any thorough diagnosis and evaluation is a comprehensive clinical interview. This conversation gathers essential information about drinking patterns, psychosocial factors, and medical history.
Core components include:
Clinicians use open‑ended questions and validated interview guides such as the Structured Clinical Interview for DSM‑5 (SCID‑5). For international patients, interpreters are available to ensure nuanced communication.
Below is a sample outline of a typical interview flow:
Accurate documentation during this stage sets the foundation for subsequent testing and treatment planning.
While AUD is primarily diagnosed through clinical criteria, a thorough physical exam and targeted laboratory tests help rule out complications and inform treatment choices.
Typical physical findings may include:
Key laboratory panels recommended during the diagnosis and evaluation process are:
At Liv Hospital, blood samples are processed in our JCI‑accredited laboratory, ensuring rapid turnaround and high analytical accuracy. Results are integrated into the patient’s electronic health record, facilitating coordinated care across specialties.
Internationally recognized classification systems provide standardized criteria for the diagnosis and evaluation of AUD. The two most widely used are the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‑5) and the International Classification of Diseases, Tenth Revision (ICD‑10).
Both systems assess severity based on the number of criteria met, but they differ in terminology and threshold.
DSM‑5 categorizes severity as mild (2‑3 criteria), moderate (4‑5), or severe (6‑11). ICD‑10 classifies the disorder as “harmful use” or “dependence syndrome,” with additional codes for withdrawal states.
Clinicians at Liv Hospital select the appropriate framework based on the patient’s country of origin, insurance requirements, and treatment goals, ensuring seamless documentation for cross‑border care.
Standardized questionnaires complement the clinical interview, providing quantifiable scores that track progress over time.
Commonly employed instruments include:
These tools are administered in the patient’s preferred language, with interpreter support when needed. Results are entered into the hospital’s digital platform, allowing clinicians to generate visual trend graphs that aid in shared decision‑making.
Accurate diagnosis and evaluation requires distinguishing AUD from other conditions that may mimic or coexist with alcohol‑related symptoms.
Key differentials include:
When comorbidities are identified, Liv Hospital’s multidisciplinary team—including hepatologists, psychiatrists, and addiction specialists—collaborates to create an integrated treatment plan that addresses all health dimensions.
Following the initial assessment, a coordinated review by specialists determines whether additional investigations are warranted.
Potential further evaluations may involve:
All findings are discussed in a case conference, ensuring that the patient’s cultural background, travel logistics, and personal preferences are respected. This holistic approach maximizes the relevance of the diagnosis and evaluation outcomes and streamlines the transition to treatment.
Liv Hospital offers JCI‑accredited, patient‑centered care designed for international patients seeking expert management of alcohol use disorder. Our multidisciplinary team combines psychiatry, hepatology, and addiction medicine expertise, while dedicated coordinators handle travel, accommodation, and interpreter services. This seamless, 360‑degree support ensures that every step of the diagnosis and evaluation process is comfortable, transparent, and aligned with global best practices.
Ready to begin your personalized assessment for alcohol use disorder? Contact Liv Hospital today to schedule a comprehensive evaluation and take the first step toward lasting recovery.
Our international patient team is standing by to assist with appointments, travel arrangements, and any questions you may have.
Liv Hospital Ulus
Psyc. Burcu Özcan
Psychology
Liv Hospital Ulus
Spec. MD. Kenan Temiz
Psychiatry
Liv Hospital Vadistanbul
Psyc. Selenay Yücel Keleş
Pediatric Psychology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Osman Yıldırım
Psychiatry
Liv Hospital Bahçeşehir
Clinic. Psy. Aleyna Didem Aydın
Psychology
Liv Hospital Bahçeşehir
Psyc. (Psychologist) Buse Yağmur
Pediatric Psychology
Liv Hospital Bahçeşehir
Psyc. Duygu Başak Gürtekin
Psychology
Liv Hospital Bahçeşehir
Spec. Psyc. Fatmanur Taşkın
Psychology
Liv Hospital Topkapı
Psyc. Merve Tokgöz
Psychology
Liv Hospital Topkapı
Spec. MD. Nesrin Köseoğlu
Pediatric and Adolescent Psychiatry
Liv Hospital Topkapı
Spec. MD. Ömür Günday Toker
Psychiatry
Liv Hospital Ankara
Asst. Prof. MD. Elif Küçük
Psychiatry
Liv Hospital Ankara
Prof. MD. Ali Bozkurt
Psychiatry
Liv Hospital Ankara
Psyc. Ecem Özcan Tatlıdil
Psychology
Liv Hospital Gaziantep
Psyc. Tuğba Annaç
Psychology
Liv Hospital Gaziantep
Spec. MD. Mustafa Çelik
Psychiatry
Liv Hospital Samsun
Psyc. (Psychologist) Ozan Yazıcı
Psychology
Liv Hospital Samsun
Spec. MD. Arda Kazım Demirkan
Psychiatry
Liv Hospital Samsun
Spec. MD. Mehmet Çevik
Psychiatry
Liv Bona Dea Hospital Bakü
MD. Dr. Nigar Novruzlu
Psychology
Spec. MD. Doğa Sevinçok
Pediatric and Adolescent Psychiatry
Send us all your questions or requests, and our expert team will assist you.
A thorough clinical interview establishes the foundation for diagnosis by exploring the patient’s drinking timeline, quantity and frequency, binge episodes, motivation to change, family and social context, and any co‑occurring conditions such as depression or anxiety. Clinicians often use structured guides like the SCID‑5 and may employ interpreters for international patients to ensure accurate and culturally sensitive information collection.
Both systems assess loss of control, tolerance, withdrawal, and continued use despite problems. DSM‑5 adds craving and time spent obtaining alcohol, requiring at least two criteria for diagnosis and categorizing severity as mild (2‑3), moderate (4‑5), or severe (6‑11). ICD‑10 (F10.2) does not include craving or time‑spent criteria and distinguishes between harmful use and dependence syndrome. Clinicians choose the framework based on the patient’s origin, insurance, and documentation needs.
Both systems assess loss of control, tolerance, withdrawal, and continued use despite problems. DSM‑5 adds craving and time spent obtaining alcohol, requiring at least two criteria for diagnosis and categorizing severity as mild (2‑3), moderate (4‑5), or severe (6‑11). ICD‑10 (F10.2) does not include craving or time‑spent criteria and distinguishes between harmful use and dependence syndrome. Clinicians choose the framework based on the patient’s origin, insurance, and documentation needs.
The Alcohol Use Disorders Identification Test (AUDIT) is a 10‑item WHO screen where scores ≥8 indicate hazardous drinking. CIWA‑Ar quantifies withdrawal severity to guide medication dosing. The Timeline Follow‑Back method uses a calendar to recall daily drinking over the past 30‑90 days, providing detailed consumption patterns. The Short Alcohol Dependence Data (SADD) evaluates dependence severity. These instruments are administered in the patient’s preferred language and stored digitally for trend analysis.
Alcohol use disorder often co‑exists with liver disease, cardiovascular problems, mental health conditions, and other substance use. A team that includes hepatologists, psychiatrists, addiction specialists, and psychologists can coordinate investigations such as neuroimaging, cardiac testing, and genetic studies, while also providing counseling and social support. This collaborative model, especially for international patients, aligns treatment with cultural preferences, travel logistics, and individual goals, improving outcomes and patient satisfaction.
For patients traveling abroad, Liv Hospital provides professional interpreters to ensure accurate communication during clinical interviews and questionnaire administration. The assessment pathway is adapted to respect cultural attitudes toward alcohol. A dedicated international patient team assists with visa, flight, lodging, and local transportation, while the multidisciplinary clinicians coordinate care across specialties, making the diagnostic journey seamless and patient‑centered.
When evaluating AUD, clinicians must differentiate alcohol‑related symptoms from conditions such as non‑alcoholic fatty liver disease (which also raises liver enzymes), medication‑induced tremor, and primary psychiatric disorders like depression or anxiety that can both result from and exacerbate drinking. Polysubstance abuse further complicates assessment. Identifying these comorbidities allows the multidisciplinary team to design an integrated treatment plan that addresses all health dimensions.
BlogBipolar DisorderFeb 03, 2026Explore how bipolar depression affects the brain and behavior, with insights into reduced gray matter, neur...
BlogBipolar DisorderFeb 03, 2026Discover the latest insights on bipolar disorder hallucinations and their significance for patient wellbeing.
BlogBipolar DisorderFeb 03, 2026Manic exhaustion in bipolar disorder is a serious condition linked to elevated mortality, with studies show...
BlogBipolar DisorderFeb 03, 2026Explore the 5 other names for bipolar disorder, from manic depression to folie a double forme. Understand t...
BlogBipolar DisorderFeb 03, 2026Understand the role of brain chemistry in bipolar hypersexuality. Our expert guide explores the duration an...
BlogBipolar DisorderFeb 03, 2026What is BD disorder? Get the facts on bipolar disorder, including its symptoms, diagnosis, and effective ma...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75